Drs. Robert Califf and Marta Sokolowska underscore the distinctive advantages primary care providers can bring to positively impacting the lives of people with opioid use disorder, referencing the Foundation’s virtual public meeting exploring “Considerations for Buprenorphine Initiation and Maintenance Care.”

Read more

In the fall of 2022, the Reagan-Udall Foundation—an independent organization established by Congress to advance the mission of the FDA—evaluated the CTP and identified several key areas for improvement. Released in December 2022, the report outlined 15 things the CTP must improve to effectively implement the regulatory goal of the organization’s mission: the protection of public health.